NASDAQ: DSGNDesign Therapeutics Inc Stock Ownership - Who owns Design Therapeutics?
Insider buying vs selling
Have Design Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when DSGN insiders and whales buy or sell their stock.
DSGN Shareholders
What type of owners hold Design Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Simeon George | 19.42% | 12,152,952 | $177.68M | Insider |
| Sr One Capital Fund I Aggregator LP | 10.43% | 6,526,476 | $95.42M | Insider |
| Sr One Capital Management LP | 10.43% | 6,526,476 | $95.42M | Institution |
| Arsani William | 9.09% | 5,687,501 | $83.15M | Insider |
| Cormorant Asset Management LP | 8.17% | 5,114,844 | $74.78M | Insider |
| Quan Venture Fund II LP | 7.54% | 4,720,830 | $69.02M | Insider |
| Stella Xu | 6.62% | 4,139,950 | $60.53M | Insider |
| Ra Capital Management LP | 4.75% | 2,972,973 | $43.46M | Institution |
| Point72 Asset Management LP | 4.35% | 2,722,754 | $39.81M | Institution |
| Baker Bros Advisors LP | 4.13% | 2,585,978 | $37.81M | Institution |
DSGN vs Biotech Stocks
Design Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.